Outlook Therapeutics, Inc. (OTLK) analyst actions
Rating and price-target actions on OTLK in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the OTLK overview →
2 measured OTLK analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Outlook Therapeutics® Reports Financial Results for Fiscal Year 2023 and Reiterates ONS-5010 Clinical and Regulatory Path Forward in the U.S. and EU | Press release | +0.70% | -3.73% | |
| Outlook Therapeutics® Announces Receipt of Type A Meeting Minutes and Reiterates Regulatory Path Forward for ONS-5010 | Press release | -0.02% | +1.57% |
Keep exploring
More OTLK: earnings → · SEC filings → · OTLK overview →